Skip to content

Clinical investigation of CCTA scan via uCT 550

Clinical investigation of CCTA scan via uCT 550

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300077101
Enrollment
Unknown
Registered
2023-10-31
Start date
2023-10-31
Completion date
Unknown
Last updated
2023-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary artery disease

Interventions

Sponsors

Shanghai Jiading District Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Age 18 to 75 years; Patients with full capacity for civil conduct; Patients with indications for coronary artery scanning; Patients who voluntarily participate in this clinical trial and sign an informed consent form.

Exclusion criteria

Exclusion criteria: Patients who do not have full capacity for civil conduct; Pregnant and lactating women; Patients who wish to have children within the next 6 months; High risk groups for contraindications and allergies to iodine contrast agents; High risk groups with contraindications and allergies to heart rate lowering drugs; For patients with renal insufficiency, the glomerular filtration rate (GFR) is less than 90 milliliters per minute (the subject must provide a renal function test certificate issued by secondary or higher hospital within one month, and if the subject is unable to provide the test certificate, they must undergo a renal function test); Patients that the investigator believes not suitable to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Clinical diagnostic requirement for compliance rate of image quality;

Secondary

MeasureTime frame
safety;

Countries

China

Contacts

Public ContactKaiyi Liang

Shanghai Jiading District Central Hospital

liangkaiyi77@163.com+86 189 3086 2735

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026